Share This

Related Topics News -

     
 Title only   |   Print 
     
《大行》大摩降國藥目標價至27元 評級「增持」

2024-04-30T  
《藍籌》國藥控股首季純利14.2億元人民幣跌10.7%

2024-04-29T  
國藥控股跌近一成 上季少賺10.7%

2024-04-29T  
國藥擬發行共300億人幣非金融企業債務融資工具

2024-04-29T  
國藥附屬國藥一致首季淨利潤3.89億人民幣 增長7.3%

2024-04-26T  
副總理劉國中赴上海調研 稱推動醫學科技創新

2024-04-25T  
《港股》恆指半日升281點 科指漲逾2% 商湯炒高31%後停牌

2024-04-24T  
《港股》恆指全日升287點 科技股強勢 理想挫逾8%

2024-04-22T  
《大行》大摩降國藥目標價至28元 評級「增持」

2024-04-19T  
歐盟傳最早4月對中國醫療器械採購啟動調查 或影響中資投標

2024-04-15T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.